The evaluation kit for the LD20-0600L single-use flow sensor is now available from distributors

The LD20 single-use liquid flow sensor series from Sensirion, the expert in flow and environmental sensor technology, is suitable for fast, precise and reliable measurements of the lowest flow rates in biomedical applications. The evaluation kit for the LD20-0600L version is now also available from distributors. The sensor manufacturer thus provides its customers with the sensor quickly and easily for initial evaluations and proof-of-concept prototype tests in small quantities.

The LD20-0600L liquid flow sensor is based on Sensirion’s proven CMOSens® Technology and optimizes costs by simplifying the design without sacrificing easy fluidic, electrical and mechanical connections. Luer lock fittings ensure safe and secure integration into the fluidic line. The straight and unobstructed flow channel design has no moving parts. Medical-grade wetted materials provide outstanding chemical resistance and excellent media compatibility. While it can provide bidirectional measurement of ultra-low flow rates up to 20 ml/h, the sensor can also be used to detect common failure modes such as occlusion, air in line or free flow with unprecedented speed and sensitivity.

Safe, precise, and reliable measurements of the lowest flow rates in a medical environment made easy: the single-use liquid flow sensors of the LD20 series measure the liquid flow rate at the point of interest for more effective patient treatment and improved safety. The intelligent, compact and cost-effective LD20 sensor series is suitable for a wide range of biomedical applications in the field of critical and home care, such as monitoring of ambulatory infusion pumps, ultra-low flow measurements of precious medications in neonatology and pediatrics, or subcutaneous flow measurement, to name but a few. Furthermore, the sensors of the LD20 series enable the development of smart medical devices and meet the needs of global trends such as point-of-care, patient compliance, complex drug administration and wearable designs. These trends are becoming even more important in light of the COVID-19 pandemic, which is increasing the need for future home-care solutions that can be remotely monitored to further substitute today’s IV therapies in a hospital setting.